Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic, safety and pharmacokinetic study of JNJ-39588146 in heart failure
2009-013929-42Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing JNJ-39588146 arm with Placebo arm (2 arms). Primary endpoints: Change in pulmonary capillary wedge pressure and Change in cardiac index. Started Nov 2009; status: completed.
02
Drugs
Urocortin 3
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2009-013929-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013929-42.